Prescription Monitoring Act public and stakeholder consultations underway12 April 2019
FREDERICTON (GNB) – The provincial government is seeking feedback from the public and stakeholders on the Prescription Monitoring Act, the legislation which informs the operations of the province’s Prescription Monitoring Program.
The act is subject to an operational review four years following the date it came into force. As part of this review, the Department of Health is requesting feedback from the public through electronic and mailed submissions, along with face-to-face consultations with stakeholder groups.
“The Prescription Monitoring Program is an important tool for health-care professionals, and it is used for intended clinical purposes,” said Health Minister Ted Flemming. “This makes it difficult to access opioids for abuse. We look forward to the consultation process so that we can ensure the act remains as effective as possible.”
The program allows New Brunswick pharmacists and prescribers to view a patient’s prescriptions for specific medications such as Dilaudid, Percocet, Ritalin and Ativan.
The program’s importance has increased over the past few years due to the ongoing challenges associated with the growing misuse of medications for pain management. The program helps health-care professionals safely prescribe drugs which have the potential for misuse, helps prevent and reduce associated harms, and supports individuals at risk of addiction.
A discussion paper on the Prescription Monitoring Act is available online.
Submissions on the Prescription Monitoring Act can be sent by email, at email@example.com, or through regular mail until 5 p.m. on Friday, May 24. Mailed submissions can be sent to: Prescription Monitoring Act Legislative Review, Department of Health, P.O. Box 5100, Fredericton, N.B., E3B 5H1.